CN Patent

CN109824657A — 一种二马来酸阿法替尼新晶型及其制备方法和应用

Assigned to CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd · Expires 2019-05-31 · 7y expired

What this patent protects

本发明涉及一种二马来酸阿法替尼新晶型及其制备方法和应用。本发明的新晶型改善了二马来酸阿法替尼已有晶型的理化性质，有很好的医药制剂流动性和可压性，可采用直接压片工艺制备三个规格的片剂，工艺简单，降低成本，大大缩短生产时间。

USPTO Abstract

本发明涉及一种二马来酸阿法替尼新晶型及其制备方法和应用。本发明的新晶型改善了二马来酸阿法替尼已有晶型的理化性质，有很好的医药制剂流动性和可压性，可采用直接压片工艺制备三个规格的片剂，工艺简单，降低成本，大大缩短生产时间。

Drugs covered by this patent

Patent Metadata

Patent number
CN109824657A
Jurisdiction
CN
Classification
—
Expires
2019-05-31
Drug substance claim
No
Drug product claim
No
Assignee
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.